Skip to content
Tuesday, November 17, 2026 · Today’s edition, 6:30 a.m. ETTue, Nov 17 · 6:30 a.m. editionSign inMy Desk 0EditionsSign in

IJHvsXPH

iShares Core S&P Mid-Cap ETF against SPDR S&P Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.

One year, growth of $100
IJH 115XPH 127Nov 25Nov 26GROWTH OF $100
Head to head
IJHXPH
Expense ratio0.050%0.35%
Assets$123.7B$528M
Net flow, 1 month+$109M+$50M
Net flow, 1 year+$10.7B+$263M
Return, YTD+10.2%+16.7%
Return, 1 year——
Avg daily volume8.1M208K
Holdings40861
ListedMay 22, 2000Jun 19, 2006
Options marketYesYes

MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS

ETF Dailyfrom Private Wealth Daily

ETF launches, fund research, and market coverage in your inbox every morning. Free.

Free. Every morning. Unsubscribe from any edition in one click.